Cargando...
Oral Levothyroxine is an Effective Option for Myxedema Coma: A Single-Centre Experience
INTRODUCTION: Myxedema coma is an endocrine emergency with a very high mortality rate. As per the American Thyroid Association, initial thyroid hormone replacement for myxedema coma should be intravenous levothyroxine (LT4). However, in India, the availability of intravenous LT4 is limited. Often, c...
Guardado en:
| Publicado en: | Eur Thyroid J |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
S. Karger AG
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7983610/ https://ncbi.nlm.nih.gov/pubmed/33777819 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000507855 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|